Quantcast
Last updated on April 16, 2014 at 13:01 EDT

Monsanto Board Approves 25 Percent Quarterly Dividend Increase To 37.5 Cents Per Share

August 8, 2012

ST. LOUIS, Aug. 8, 2012 /PRNewswire/ — Monsanto Company (NYSE: MON) announced today that its Board of Directors declared a quarterly dividend on its common stock of 37.5 cents per share, representing an increase of 25 percent. The dividend relates to the company’s fourth quarter of its 2012 fiscal year and is payable on October 26, 2012 to shareowners of record on October 5, 2012.

“Our strong cash flow position gives us the opportunity to prioritize the value we can return to shareowners,” said Pierre Courduroux, senior vice president and chief financial officer for Monsanto. “The increase in our quarterly dividend underscores this commitment to the shareowners of our company and supports our objective of maximizing shareowner value.”

Courduroux noted that Monsanto’s approach to using its cash position to benefit its owners revolves around providing direct return through dividends and share repurchases, as well as using cash for strategic acquisitions and capital spending. As part of its overall cash deployment approach, in June, Monsanto announced a new three-year share repurchase program, effective July 1, 2012, for up to $1 billion of the company’s common stock.

About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world’s natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com. Follow our business on Twitter(®) at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows at www.monsantoblog.com, or subscribe to our News Release RSS Feed.

Cautionary Statements Regarding Forward-Looking Information:
Certain statements contained in this release are “forward-looking statements,” such as statements concerning the company’s anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company’s exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company’s research and development activities; the outcomes of major lawsuits and the previously-announced SEC investigation; the previously reported material weakness in our internal controls over financial reporting; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company’s estimates related to distribution inventory levels; the company’s ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company’s facilities; and other risks and factors detailed in the company’s most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

    CONTACT                       Media - Sara
                                  Miller
                                  (314-694-5824)

SOURCE Monsanto Company


Source: PR Newswire